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Hypoxia-induced sensitisation 
of TRPA1 in painful dysesthesia 
evoked by transient hindlimb 
ischemia/reperfusion in mice
Kanako So1, Yuna Tei2, Meng Zhao1, Takahito Miyake1, Haruka Hiyama1, Hisashi Shirakawa1, 
Satoshi Imai2, Yasuo Mori3, Takayuki Nakagawa2, Kazuo Matsubara2 & Shuji Kaneko1
Dysesthesia is an unpleasant abnormal sensation, which is often accompanied by peripheral 
neuropathy or vascular impairment. Here, we examined the roles of transient receptor potential 
ankyrin 1 (TRPA1) in dysesthesia-like behaviours elicited by transient hindlimb ischemia (15–60 min) 
by tightly compressing the hindlimb, and reperfusion by releasing the ligature. The paw-withdrawal 
responses to tactile stimulation were reduced during ischemia and lasted for a while after reperfusion. 
Hindlimb ischemia/reperfusion elicited spontaneous licking of the ischemic hindpaw that peaked within 
10 min. The licking was inhibited by reactive oxygen species (ROS) scavengers, a TRPA1 antagonist, or 
TRPA1 deficiency, but not by TRPV1 deficiency. In human TRPA1-expressing cells as well as cultured 
mouse dorsal root ganglion neurons, the H2O2-evoked TRPA1 response was significantly increased by 
pretreatment with hypoxia (80 mmHg) for 30 min. This hypoxia-induced TRPA1 sensitisation to H2O2 
was inhibited by overexpressing a catalytically-inactive mutant of prolyl hydroxylase (PHD) 2 or in a 
TRPA1 proline mutant resistant to PHDs. Consistent with these results, a PHD inhibitor increased  
H2O2-evoked nocifensive behaviours through TRPA1 activation. Our results suggest that transient 
hindlimb ischemia/reperfusion-evoked spontaneous licking, i.e. painful dysesthesia, is caused by ROS-
evoked activation of TRPA1 sensitised by hypoxia through inhibiting PHD-mediated hydroxylation of a 
proline residue in TRPA1.
Dysesthesia is an unpleasant abnormal sensation, typically burning, tingling, pricking, and pins-and-needles, 
which can be spontaneous or provoked by external stimuli. However, dysesthesia is often accompanied by pain, 
paresthesia (abnormal sensation), and numbness (decrease or loss of sensation)1,2. Dysesthesia is associated with 
various diseases, such as diabetic neuropathy, peripheral entrapment neuropathy, polyneuropathy, peripheral 
arterial disease, and chemotherapy-induced peripheral neuropathy, causing problems during clinical care3–7. 
Currently, however, no effective therapeutic drugs are available specifically for treating dysesthesia, mostly 
because the molecular mechanisms underlying dysesthesia are largely unknown.
Dysesthesia can be induced by either the structural or functional disturbance of primary sensory neurons. 
In the latter case, the peripheral vascular impairment of peripheral arterial diseases induces cold sensation, 
dysesthesia, and numbness in the early stage, with increasing pain in the lower extremities as disease pro-
gresses3,8–10. These clinical findings suggest that hypoxia around sensory neurons is responsible for dysesthe-
sia. Thus, several pain models induced by hindlimb ischemia or ischemia/reperfusion have been used. In the 
chronic post-ischemic pain model, prolonged hindlimb ischemia for 3 h and reperfusion cause mechanical 
and cold hyperalgesia/allodynia and spontaneous pain behaviours beginning 8 h after the reperfusion and 
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lasting for several weeks, although this model is recognised as a model for complex regional pain syndrome 
type I11–14. Similarly, ischemic pain models induced by femoral artery thrombus or occlusion have been 
reported15–17. Evidence using these animal models suggests that oxidative stress produced by ischemia or 
ischemia/reperfusion contributes to the ischemic pain11,17–19.
Transient receptor potential ankyrin 1 (TRPA1), a nonselective cation channel, is highly expressed in a subset 
of nociceptive C-fibres and acts as a polymodal nociceptor20. TRPA1 is activated by a large number of irritants, 
reactive oxygen and nitrogen species (ROS/RNS), as well as hyperoxia, through reversible covalent or oxida-
tive modification of cysteine residues at the N-terminal on TRPA121–28. By contrast, TRPA1 is also activated by 
hypoxia; hypoxia inhibits the activity of oxygen-sensitive prolyl hydroxylases (PHDs) and relieves TRPA1 from 
inhibition by PHD-mediated hydroxylation of a proline residue within the N-terminal ankyrin repeat domain 
of TRPA126. On the other hand, we previously reported that the acute peripheral neuropathy characteristically 
induced by oxaliplatin, a platinum-based chemotherapeutic agent, is caused by enhanced responsiveness of 
TRPA1, but not TRPV1 and TRPM8, in mice29.
Recently, Sasaki et al. reported that transient hindlimb ischemia in mice induced by compression for 1–10 min 
and reperfusion provokes spontaneous licking of the ischemic hindpaw and suggests the involvement of ROS 
generation and TRPA1 activation30. However, the mechanisms through which these events occur remain unclear. 
In the present study, to elucidate the molecular mechanisms underlying behaviours indicative of dysesthesia in 
mice following transient hindlimb ischemia/reperfusion, we investigated how TRPA1 is activated or sensitised by 
ROS in vivo and in vitro. Here, we show that hypoxia induces TRPA1 sensitisation to hydrogen peroxide (H2O2) 
by inhibiting the PHD-mediated hydroxylation of an N-terminal proline residue in TRPA1.
Results
Hindpaw blood flow is altered during hindlimb ischemia and reperfusion. We observed the 
appearance of the hindpaws and measured hindpaw blood flow in mice during a compressive ligation (ischemia) 
of the hindlimb with a string and after relief from the compression (reperfusion). During hindlimb ischemia, the 
ipsilateral hindpaw showed cyanosis, and, immediately after reperfusion, it appeared red and swollen (Fig. 1a). 
Consistent with these observations, blood flow of the compressed hindpaw during ischemia was reduced to less 
than 25% of that in the contralateral hindpaw. Immediately after reperfusion, blood flow was transiently increased 
and gradually returned to the control level within 60 min (Fig. 1b).
Hypoesthesia during hindlimb ischemia and after reperfusion. To determine whether transient 
hindlimb ischemia and reperfusion affect tactile sensation, the paw-withdrawal responses to von Frey filament 
and brush stimuli were assessed during ischemia and after reperfusion (Fig. 2). In the von Frey filament test, 
the scores for the paw-withdrawal response of the contralateral hind paw tended to be decreased only during 
hindlimb ischemia. The scores for the ipsilateral hind paw were significantly decreased by hindlimb ischemia 
for 15 min (F1,10 = 7.24, p < 0.05), 30 min (F1,10 = 20.1, p < 0.01), and 60 min (F1,10 = 37.5, p < 0.001). When mice 
were exposed to hindlimb ischemia for 15 min, the decreased score immediately returned to the control level just 
after reperfusion. By contrast, when mice were exposed to hindlimb ischemia for 30 and 60 min, the scores of 
the paw-withdrawal responses were significantly reduced until 15 and 60 min after the reperfusion, respectively, 
compared with those for the contralateral hind paw, and then gradually returned to control levels. Similarly, in 
the brush test, hindlimb ischemia/reperfusion for 60 min significantly reduced the scores of the paw-withdrawal 
responses (F1,10 = 76.5, p < 0.001). The significant decreases were observed until 30 min after reperfusion.
Hindlimb ischemia/reperfusion evokes spontaneous licking behaviour. When mice were exposed 
to hindlimb ischemia for 60 min followed by relief from the ischemia, spontaneous licking of the ipsilateral hind-
paw was observed immediately after reperfusion, whereas other escape behaviours, such as flicking, were rarely 
Figure 1. Changes in hindpaw blood flow induced by transient hindlimb ischemia/reperfusion. To 
induce transient hindlimb ischemia in mice, the left hindlimb just proximal to the ankle joint was compressed 
by ligation with a string for 60 min. The ligature was rapidly removed for reperfusion. (a) Representative 
photographs (upper panels) and blood flow images (lower panels) of the hindpaws of a mouse before and during 
ischemia and just after reperfusion. (b) The blood flow in the ipsilateral hindpaw was normalised to that in the 
contralateral hindpaw, and the value obtained just before ischemia served as 100%. Data are presented as means 
of the percentage ± S.E.M. n = 3.
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observed (Supplementary Video). When recorded every 1 min for 20 min, the duration of licking was significantly 
increased (F1,11 = 95.4, p < 0.001). The significant increases were observed during 2–7 min after reperfusion, com-
pared with that in sham-treated mice, and the licking peaked at 5 min (Fig. 3a). When mice were exposed to 
hindlimb ischemia for 15, 30 or 60 min and the time spent licking was recorded every 5 min for 40 min after 
reperfusion, the duration of licking was significantly increased (F3,29 = 58.6, p < 0.001) at 5 and 10 min after reper-
fusion, compared with that in sham-treated mice. The licking once disappeared at 15 and 20 min, but was slightly 
increased again thereafter until 40 min after the reperfusion following 60-min hindlimb ischemia. However, such 
biphasic licking was not observed by 15- and 30-min hindlimb ischemia (Fig. 3b). The total duration of the 
time spent licking during 40 min was significantly increased at an ischemic time-dependent manner (Fig. 3c; 
F3,29 = 21.4, p < 0.001). When analysed in the early (0–10 min) and delayed phases (10–40 min) of licking, the for-
mer was significantly increased by either 15-, 30- or 60-min hindlimb ischemia, while the latter was significantly 
increased only by 60-min, but not 15- and 30-min, hindlimb ischemia (Supplementary Fig. S1).
We selected a hindlimb ischemia of 60 min as our model of dysesthesia accompanied by tactile hypoesthesia 
and the delayed phase of spontaneous licking for the following experiments.
Involvement of ROS and TRPA1 in hindlimb ischemia/reperfusion-evoked licking. Following 
ischemia, reperfusion of oxygenated blood into ischemic tissues induces ROS production, which causes oxi-
dative injury31,32. In the hindlimb ischemic/reperfused paws, the content of H2O2 was significantly increased 
compared with that in the contralateral paws (Fig. 4a). To determine whether ROS is involved in the transient 
hindlimb ischemia/reperfusion-evoked licking, we examined the effects of the membrane-permeable ROS scav-
engers 4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPOL) and α -phenyl-tert-butyl nitrone (PBN). 
Compared with the administration of saline, the intraperitoneal (i.p.) administration of TEMPOL (250 mg/kg) 
or PBN (100 mg/kg) 15 min before reperfusion significantly attenuated the duration of licking in ischemic/rep-
erfused mice (F2,15 = 22.7, p < 0.001), with no effect in sham-treated mice (Fig. 4b). When analysed in the early 
(0–10 min) and delayed phases (10–40 min) of licking, both phases were significantly attenuated by TEMPOL 
or PBN (Supplementary Fig. S2). By contrast, neither TEMPOL (250 mg/kg) nor PBN (100 mg/kg) affected 
the nocifensive behaviour evoked by an intraplantar injection of a TRPA1 agonist, allyl isothiocyanate (AITC) 
(Supplementary Fig. S3). These findings suggest that TEMPOL and PBN can attenuate the licking behaviour via 
ROS production by hindlimb ischemia/reperfusion, but not TRPA1 stimulation-evoked nocifensive behaviours.
Next, we investigated the roles of redox-sensitive TRPA126,27 in hindlimb ischemia/reperfusion-evoked 
licking by using TRPA1-knockout (TRPA1-KO) mice. There was no significant difference in the alterations 
of the hindpaw blood flow between wild-type (WT) and TRPA1-KO mice (F1,8 = 0.16, p = 0.70) (Fig. 4c). The 
Figure 2. Tactile hypoesthesia during hindlimb ischemia and after reperfusion. (a–c) The static tactile 
responses to a von Frey filament were measured immediately before and during hindlimb ischemia for 15 
(a), 30 (b), and 60 min (c), and after reperfusion. (d) The dynamic tactile responses to paintbrush stroking 
were measured immediately before and during hindlimb ischemia for 60 min, and after reperfusion. The paw-
withdrawal responses in the contralateral and ipsilateral hindpaws were scored. n = 6, **P < 0.01, ***P < 0.001 
vs. contralateral.
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paw-withdrawal response to von Frey filament stimulation in WT and TRPA1-KO mice were similarly reduced 
during hindlimb ischemia and after reperfusion. There was no significant difference between them (F1,9 = 1.78, 
p = 0.21) (Fig. 4d). By contrast, the duration of the hindlimb ischemia/reperfusion-evoked licking was signif-
icantly attenuated in TRPA1-KO mice compared with that in WT mice, whereas it remained unchanged in 
TRPV1-KO mice (Fig. 4e). The i.p. administration of HC-030031, a TRPA1 antagonist (10, 30 and 50 mg/kg), 
immediately before initiating ischemia significantly attenuated the duration of licking in a dose-dependent man-
ner (F3,21 = 20.0, p < 0.011). Compared with the vehicle-administered group, significant effects of HC-030031 
were observed at 30 and 50 mg/kg, and no effect of HC-030031 was observed in sham-treated mice (Fig. 4f). 
When analysed in the early (0–10 min) and delayed phases (10–40 min) of licking, both phases were significantly 
attenuated by TRPA1 deficiency or HC-030031, but not by TRPV1 deficiency (Supplementary Fig. S4).
Hypoxia enhances H2O2-evoked TRPA1 activation. Using fluorometric Ca2+ imaging analysis, 
we investigated the effects of hypoxia on TRPA1 activation in response to H2O2 in HEK293 cells expressing 
human TRPA1 (hTRPA1). When the oxygen (O2) concentration in Krebs-Ringer buffer was abruptly decreased 
from a partial O2 pressure (PO2) of 160 mmHg (21% O2) to 80 mmHg (10.5% O2), the intracellular Ca2+ con-
centration ([Ca2+]i) was rapidly increased in many hTRPA1-expressing cells (Supplementary Fig. S5), consist-
ent with a previous report26. However, when the O2 concentration in the buffer was gradually decreased to a 
PO2 of 80 mmHg, only a few hTRPA1-expressing cells responded (Supplementary Fig. S6). The O2 concentra-
tion of atmospheric PO2 (160 mmHg) was decreased over 20–30 min to the hypoxic PO2 of 80 mmHg. Those 
cells responding to hypoxia were excluded from the analyses. Following pretreatment with hypoxia at a PO2 of 
80–100 mmHg for 30 min, we rapidly returned the O2 concentration to a PO2 of approximately 160 mmHg and 
concomitantly applied H2O2 (10 μM) dissolved in normoxic buffer. In order to better detect alterations of TRPA1 
function, we set a low H2O2 concentration of 10 μM. In mock-transfected cells, the application of H2O2 had no 
effect on [Ca2+]i following pretreatment with either normoxia (160 mmHg) or hypoxia (80 mmHg) (Fig. 5a,d). 
In hTRPA1-expressing cells pretreated with normoxia (160 mmHg) for 30 min, the application of 10 μM H2O2 
had no or little effect on [Ca2+]i (Fig. 5b). By contrast, robust H2O2-evoked [Ca2+]i increases were observed in 
many cells pretreated with hypoxia (80 mmHg) for 30 min (Fig. 5c). Quantitative analyses revealed that pre-
treating with hypoxia at a PO2 of 100 mmHg (13.2% O2), 90 mmHg (11.8% O2), or 80 mmHg (10.5% O2) for 
30 min significantly enhanced the change in the F340/F380 ratio (ΔRatio) of the H2O2-evoked [Ca2+]i increase in 
an O2 concentration-dependent manner (F3,20 = 9.02, p < 0.001). A significant difference was observed at a PO2 
of 80 mmHg (Fig. 5e).
Similarly, the effects of hypoxia pretreatment on the H2O2-evoked Ca2+ responses were investigated in cultured 
dorsal root ganglion (DRG) neurons isolated from WT or TRPA1-KO mice. In WT DRG neurons pretreated with 
Figure 3. Spontaneous licking following transient hindlimb ischemia/reperfusion. Time course of 
spontaneous licking after reperfusion following a transient hindlimb ischemia for 15, 30 and 60 min. (a) The 
time spent licking the ipsilateral hindpaw was measured every 1 min for 20 min after reperfusion following 
60-min hindlimb ischemia (n = 7) or sham treatment (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001 vs sham 
treatment. (b,c) The time spent licking the ipsilateral hindpaw every 5 min for 40 min (b) and total time spent 
licking for 40 min (c) was measured after reperfusion following 15, 30 or 60-min hindlimb ischemia/reperfusion 
or sham treatment. n = 4–15, **P < 0.01, ***P < 0.001 vs sham treatment.
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Figure 4. Involvement of reactive oxygen species (ROS) and TRPA1 in the hindlimb ischemia/reperfusion-
evoked spontaneous licking. (a) H2O2 production following the hindlimb ischemia/reperfusion. The H2O2 
contents (nmol/mg protein) in the contralateral (contra) and ipsilateral (ipsi) paws 5 min after reperfusion 
following 60-min hindlimb ischemia were measured. n = 5, *P < 0.05, vs contralateral. (b) Effects of ROS 
scavengers on the hindlimb ischemia/reperfusion-evoked spontaneous licking. 4-hydroxy-2,2,6,6-tetramethyl-
1-piperidinyloxy (TEMPOL; 250 mg/kg), α -phenyl-tert-butyl nitrone (PBN; 100 mg/kg), or vehicle was 
administered intraperitoneally (i.p.) 15 min before reperfusion following 60-min hindlimb ischemia or sham 
treatment. The time spent licking was measured for 40 min after reperfusion following hindlimb ischemia of 
60 min. n = 6, ***P < 0.001. (c) Wild-type (WT) or TRPA1-knockout (KO) mice were subjected to hindlimb 
ischemia/reperfusion, and blood flow was measured in both the contralateral and ipsilateral hindpaws. Blood 
flow in the ipsilateral hindpaw was normalised to that in the contralateral hindpaw, and the value obtained just 
before ischemia served as 100%. n = 5. No difference in blood flow is observed between WT and TRPA1-KO 
mice. (d) The static tactile responses to a von Frey filament in WT and TRPA1- KO mice were measured during 
hindlimb ischemia and after reperfusion. The paw-withdrawal responses in the ipsilateral hindpaw were scored. 
n = 5–6. (e) The time spent licking in WT, TRPA1-KO, or TRPV1-KO mice was measured for 40 min following 
hindlimb ischemia/reperfusion. n = 5–9. **P < 0.01. N.S. = not significant. (f) The TRPA1 antagonist HC-
030031 (10, 30, and 50 mg/kg) or vehicle was administered i.p. immediately before initiating ischemia or in 
sham-treated mice. The time spent licking was measured for 40 min following hindlimb ischemia/reperfusion. 
n = 5–7, **P < 0.01, ***P < 0.001.
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normoxia (160 mmHg) for 30 min, the application of 100 μM H2O2 increased [Ca2+]i in 20.9 ± 5.8% of the DRG 
neurons. Pretreatment with hypoxia (80 mmHg) for 30 min enhanced the H2O2-evoked [Ca2+]i increase. The 
number of H2O2-sensitive neurons pretreated with hypoxia was significantly greater than that pretreated with 
normoxia (Fig. 6a–c). By contrast, few TRPA1-KO DRG neurons responded to 100 μM H2O2. Pretreatment with 
hypoxia (80 mmHg) for 30 min did not affect the number of H2O2-sensitive cells. The number of H2O2-sensitive 
cells in TRPA1-KO DRG neurons did not differ under normoxic and hypoxic conditions (Fig. 6d–f).
Involvement of PHD and an N-terminal proline residue of TRPA1 in hypoxia-induced TRPA1 
sensitisation to H2O2. Hypoxia diminishes the activity of PHDs33,34 and activates TRPA1 through relief 
from PHD-mediated hydroxylation of proline residue 394 (Pro394) of hTRPA126. To determine whether the 
hypoxia-enhanced TRPA1 response to H2O2 is mediated through the PHD-inhibition and dehydroxylation of 
the hTRPA1 Pro394, we used a catalytically inactive dominant negative mutant of human PHD2 (mutPHD2) 
and an hTRPA1 Pro394 mutant to alanine (hTRPA1-P394A), which has no interaction with PHDs26. In HEK293 
cells cotransfected with hTRPA1 and a vector (mock), pretreatment with hypoxia (80 mmHg) for 30 min signif-
icantly enhanced the H2O2-evoked [Ca2+]i increase compared with that observed under normoxic conditions 
(160 mmHg). In cells cotransfected with hTRPA1 and mutPHD2, the H2O2-evoked [Ca2+]i increase tended to 
be high, even following normoxia pretreatment. However, hypoxia pretreatment did not affect the H2O2-evoked 
[Ca2+]i increase, and the response of the normoxia- and hypoxia-pretreated cells was not different (Fig. 7a). 
Similarly, in hTRPA1-P394A-expressing cells, the H2O2-evoked [Ca2+]i increase tended to be high, even following 
normoxia pretreatment, but there was no difference in the response between normoxia- and hypoxia-pretreated 
cells (Fig. 7b).
PHD inhibitor enhances H2O2-evoked nocifensive behaviours through TRPA1 activation. 
Finally, we investigated whether the PHD inhibitor dimethyloxalylglycine (DMOG) enhances TRPA1-mediated 
nocifensive behaviours in mice. In mice pretreated intraplantarly (i.pl.) with vehicle, an i.pl. injection of H2O2 
(0.5%, 20 μL/paw), but not saline, evoked nocifensive behaviours, including licking and flicking of the injected 
paw. The time spent in H2O2-evoked nocifensive behaviour was significantly increased in mice pretreated 
with DMOG (25 μg/paw) compared with that in vehicle-pretreated mice. Pre-administration of HC-030031 
(100 mg/kg, i.p.) significantly attenuated the increased DMOG-induced time spent in H2O2-evoked nocifensive 
behaviour but had no effect in vehicle-pretreated mice (Fig. 8).
Figure 5. Effects of hypoxia on H2O2-evoked TRPA1 activation in hTRPA1-expressing cells. HEK293 cells 
transfected with vector (a,d; mock) or hTRPA1 cDNA (b,c,e) were pretreated with normoxia (160 mmHg) 
or hypoxia (100, 90, or 80 mmHg) for 30 min, and then exposed to H2O2 (10 μM) for 5 min, as shown in 
Supplementary Fig. S5. (a–c) Representative images of [Ca2+]i changes are shown as F340/F380 ratio. F340/F380 
ratio in each cell is shown as pale-coloured lines, and the average of F340/F380 ratio is shown as a black solid 
line. (d,e) Statistical analyses of H2O2-evoked [Ca2+]i increases were calculated as the average of the maximal 
ΔRatio during the 5 min H2O2 application period (33–38 min) obtained from 5–6 independent experiments, 
as described in Materials and Methods. AITC, allyl isothiocyanate, 100 μM; Iono, ionomycin, 3 μM. **P < 0.01, 
compared with normoxia (160 mmHg). N.S. = not significant.
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Discussion
In humans, reperfusion following ischemia of an upper or lower limb often induces dysesthesia accompanied by 
pain and numbness. In this study, we provided the first evidence that peripheral ischemia/reperfusion-evoked 
Figure 6. Effects of hypoxia on the H2O2-evoked TRPA1 activation in cultured mouse dorsal root ganglion 
(DRG) neurons. Cultured mouse DRG neurons prepared from WT (a–c) or TRPA1-KO (d–f) mice were 
pretreated with normoxia (160 mmHg) or hypoxia (80 mmHg) for 30 min, and then exposed to H2O2 (100 μM) 
for 5 min, as shown in Supplementary Fig. S5. (a,b,d,e) Representative images of [Ca2+]i changes are shown as 
F340/F380 ratio. (c,f) Statistical analyses of H2O2-evoked [Ca2+]i increases were calculated as the percentage of 
H2O2-sensitive cells in 50 mM KCl-sensitive neurons obtained from 5–6 independent experiments, described in 
the Materials and Methods. AITC, allyl isothiocyanate, 100 μM; Cap, capsaicin, 0.3 μM; KCl, 50 mM. *P < 0.05. 
N.S. = not significant.
Figure 7. Involvement of prolyl hydroxylase (PHD) and Pro394 in the hypoxia-induced TRPA1 sensitisation 
to H2O2. (a,b) HEK293 cells cotransfected with human TRPA1 (hTRPA1) and a vector (mock) or a dominant 
negative mutant of hPHD2 (mutPHD2) cDNAs (a), or transfected with hTRPA1-P394A cDNA (b), were 
pretreated with normoxia (160 mmHg) or hypoxia (80 mmHg) for 30 min, and then exposed to H2O2 (10 μM). 
Statistical analyses of H2O2-evoked [Ca2+]i increases were calculated as the average of the ΔRatio during the 
5 min H2O2 application obtained from five independent experiments. *P < 0.05. N.S.  = not significant.
www.nature.com/scientificreports/
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spontaneous licking, i.e., painful dysesthesia observed in mice, is caused by the hypoxia-induced TRPA1 sensi-
tisation to ROS through inhibition of PHD-mediated hydroxylation of an N-terminal proline residue in TRPA1.
A variety of animal models of semi-permanent hindlimb ischemia are widely used for evaluation of the 
pathophysiology of peripheral arterial disease35–38 as well as of ischemic pain15,16. In addition, a body of evi-
dence suggests that reperfusion following transient hindlimb ischemia for several hours can induce long-lasting 
post-ischemic pain, although the onset and peak time are delayed until several days after the reperfusion11,12,17,19. 
By contrast, the present results demonstrated that reperfusion following transient hindlimb ischemia for 
15–60 min rapidly evoked spontaneous licking, which then immediately ceased. Considering its rapid onset and 
offset, the ischemia/reperfusion-evoked spontaneous licking is different from the delayed onset of long-lasting 
post-ischemic pain. The spontaneous liking may be caused by the functional neuropathy, rather than structural 
injury, induced by transient hindlimb ischemia/reperfusion. Consistently, Sasaki et al. reported that shorter 
hindlimb ischemia (1–10 min) evokes similar spontaneous licking, which appeared during the first 10-min 
period immediately after the reperfusion, but then disappeared30. By contrast, we found that longer hindlimb 
ischemia (60 min) evoked biphasic spontaneous licking, which was composed of early (0–10 min) and delayed 
phases (10–40 min). The former is similar to the previous report30, while the latter is likely to be elicited only by 
longer hindlimb ischemia. Another characteristic feature of the present model is that the tactile hypoesthesia 
lasted for a while, even after reperfusion following longer hindlimb ischemia of more than 30 min, indicating that 
spontaneous licking accompanies hypoesthesia. Although it may appear that these sensations are conflicting, 
clinical findings clearly show that dysesthesia includes or accompanies various sensations, such as paresthesia 
and numbness1,2. However, the duration of hypoesthesia after reperfusion is dependent on the time of compres-
sive ischemia, but independent of the time of ischemia/reperfusion-evoked spontaneous licking. Furthermore, 
TRPA1 deficiency reduced ischemia/reperfusion-evoked licking, but not hypoesthesia. Taken together, our data 
suggest that dysesthesia and hypoesthesia are independent and are based on different mechanisms.
Accumulating evidence suggests that ROS produced by ischemia/reperfusion is a key player in post-ischemic 
pain11,17,18. Ischemia/reperfusion-induced injury of sensory nerves is caused by excess ROS, which can lead to 
lipid peroxidation, protein oxidization, calcium overload, DNA damage, and the production of inflammatory 
cytokines32,39. In addition to these ROS-mediated cytotoxic effects, ROS can specifically activate redox-sensitive 
TRP channels, including TRPA1 and TRPV127. The present findings suggest that ROS produced by transient 
hindlimb ischemia/reperfusion evokes spontaneous licking through activation of TRPA1, but not TRPV1. This 
finding is supported by a previous finding that mitochondrial dysfunction preferentially activates TRPA1, but 
not TRPV1, through ROS production derived from mitochondria40. The ROS/TRPA1-mediated spontaneous 
licking behaviour predominantly represents the painful aspect of dysesthesia. We found that both early and 
delayed phases of spontaneous licking were suppressed by ROS scavengers and TRPA1 blockade. The former is 
likely to be elicited by ROS and TRPA1 activation, similar to the previous report30. However, the latter mecha-
nism is still unclear, because it may be due to secondary responses induced by early ROS/TRPA1 activation, like 
the second phase of formalin-induced nocifensive behaviors. On the other hand, TRPA1 has been shown to be 
involved in the vasoconstriction and vasodilatation responses to cold exposure via ROS production and calci-
tonin gene-related peptide/substance P release, respectively41. The present results suggest, however, that TRPA1 
is unlikely to be involved in the decrease, transient increase, and recovery of hindpaw blood flow induced by 
hindlimb compressive ligation and its relief.
The major finding of this study is that hypoxia enhances the sensitivity of TRPA1 to ROS. To mimic the 
transient hindlimb ischemia/reperfusion in vitro, TRPA1-expressing cells or mouse cultured DRG neurons 
were pretreated with hypoxia and then subjected to H2O2 with reoxygenation. TRPA1 is activated by H2O2, as 
Figure 8. Effect of a prolyl hydroxylase (PHD) inhibitor on H2O2-evoked nocifensive behaviours. Mice 
were injected i.pl. with the PHD inhibitor dimethyloxalylglycine (DMOG; 25 μg/paw) or saline. One hour after 
the pretreatment, mice were injected with H2O2 (1.5%, 20 μL/paw) or saline. The time mice spent in H2O2-
evoked nocifensive behaviours, such as ipsilateral paw licking and flicking, was measured for 5 min. The TRPA1 
antagonist HC-030031 (100 mg/kg) or vehicle was administered i.p. 30 min before the H2O2 injection. n = 5–8, 
***P < 0.001.
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well as hyperoxia, through oxidative modification of the cysteine residues at the N-terminal of TRPA126–28,42,43, 
whereas hypoxia relieves TRPA1 from inhibition by PHD-mediated hydroxylation, leading to TRPA1 activa-
tion26. However, we found that pretreatment with hypoxia enhanced H2O2-evoked TRPA1 activation, i.e., 
TRPA1 sensitisation to ROS. The PO2 that induced TRPA1 sensitisation was approximately 80 mmHg, which 
corresponds to that for hypoxia-induced TRPA1 activation26, suggesting that hypoxia-induced TRPA1 activa-
tion and sensitisation are closely related. In TRPA1-KO DRG neurons, the H2O2-evoked [Ca2+]i response was 
not observed, even after pretreatment with hypoxia. This result suggests that hypoxia selectively enhances the 
sensitivity of TRPA1, but not other ROS-sensitive channels, in DRG neurons42,43. Thus, TRPA1 plays a pivotal 
role in ROS-mediated responses of sensory neurons induced by peripheral ischemia/reperfusion. However, we 
can not fully exclude the possible involvement of other mechanisms than ROS-mediated TRPA1 activation in 
the ischemia/reperfusion-evoked spontaneous licking, because TRPA1 deficiency did not completely vanish the 
behaviour.
The TRPA1 Pro394 residue is normally hydroxylated by PHDs in normoxia, which induces internalization 
of TRPA1 and suppresses TRPA1 activation. When PHD activity is inhibited by hypoxia, unmodified TRPA1 
proteins are inserted into the plasma membrane and then activated26. In the present study, we found that the 
hypoxia-induced TRPA1 sensitisation to ROS was attenuated by overexpression of mutPHD2 or in hTR-
PA1-P394A-expressing cells. These results suggest that the hypoxia-induced TRPA1 sensitisation is caused 
by inhibiting the PHD-mediated hydroxylation of the TRPA1 Pro394 residue, similar to the mechanism of 
hypoxia-induced TRPA1 activation. This finding is further supported by our in vivo behavioural experiments 
in which H2O2-evoked nocifensive behaviour through TRPA1 was enhanced by a PHD inhibitor. However, fur-
ther investigations will be needed to determine whether inhibiting the hydroxylation of Pro394 increases TRPA1 
localization in the plasma membrane or enhances the ROS-mediated oxidative sensitivity of N-terminal cysteine 
residues on TRPA1.
In conclusion, our data suggest that post-ischemic painful dysesthesia following a transient compressive hind-
limb ischemia/reperfusion is caused by ROS-evoked activation of TRPA1 sensitised by hypoxia through inhibi-
tion of PHD-mediated hydroxylation of the TRPA1 Pro394 residue. The present findings elucidate a molecular 
mechanism underlying peripheral vascular neuropathy and suggest that hypoxia-induced TRPA1 sensitisation 
plays a pivotal role in painful dysesthesia.
Materials and Methods
Animals. All experiments were performed according to the ethical guidelines recommended by the Kyoto 
University Animal Research Committee. The protocol was approved by the Kyoto University Animal Research 
Committee (permit number: 2014–45, 2015–38). All efforts were made to minimise the number of animals used 
and limit experimentation to only what was necessary. Male ICR mice aged 6–7 weeks were purchased from Japan 
SLC (Shizuoka, Japan). TRPA1-KO mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA) and 
genotyped as previously described23. TRPV1-KO mice were a gift from Dr. David Julius (University of California, 
San Francisco, USA). Each KO mouse line was backcrossed with C57BL/6J mice for 7 to 10 generations to elim-
inate any background effects on the phenotypes. All mice were housed under constant ambient temperature 
(24 ± 1 °C) and humidity (55 ± 10%), with alternate light–dark cycles from 8:00 a.m. to 8:00 p.m. Food and water 
were freely available.
Drugs and reagents. TEMPOL and PBN (Sigma-Aldrich, St. Louis, MO, USA) were freshly dissolved in 
sterile saline. HC-030031 (Haoyuan Chemexpress, Shanghai, China) was freshly suspended in 0.5% methylcel-
lulose (Wako Pure Chemical Industries, Osaka, Japan). DMOG (Frontier Scientific, Logan, UT, USA) and H2O2 
(Wako) were freshly dissolved in sterile saline for intraplantar administration. Allyl isothiocyanate (AITC; Wako) 
and capsaicin (Sigma-Aldrich) were dissolved in dimethyl sulfoxide in Krebs-Ringer buffer for Ca2+ imaging 
experiments. All other reagents were of the best available quality from commercial sources.
Dysesthesia model induced by transient hindlimb ischemia/reperfusion. Hindlimb ischemia was 
induced by compression with a string. Under isoflurane anaesthesia, the mouse’s left hindlimb just proximal to the 
ankle joint was tightly ligated using a string (No. 20; Pocket, Sanda, Japan) to induce ischemia (Fig. 1a). The mice 
were returned to an observation cylinder to recover from the anaesthesia, except for the experiments measuring 
hindpaw blood flow. To keep the mice from biting and cutting the string, they were fitted with an Elizabethan 
collar (Lomir Biomedical Inc., Malone, NY) during hindlimb compression. After 15–60 min of ischemia, the 
ligature was quickly removed by cutting the string to allow for hindlimb reperfusion. Sham-treated mice received 
identical treatment, except their hindlimbs were not compressed with a string.
Measurement of hindpaw blood flow. Mice were anaesthetised with pentobarbital (64.8 mg/kg, i.p.). 
The blood flow of non-ischemic right (contralateral) and ischemic left (ipsilateral) hindpaws was measured using 
a laser speckle blood flow analysing system (OMEGA ZONE, Omega wave Co., Tokyo, Japan) at the times indi-
cated. To avoid data variations caused by ambient light and temperature, the blood flow in the ipsilateral hindpaw 
was normalised to that in the contralateral hindpaw.
Behavioural tests. Spontaneous licking induced by a transient hindlimb ischemia/reperfusion. Mice were 
individually habituated to the experimental conditions in an acrylic observation cylinder (diameter, 30 cm; 
height, 50 cm) for approximately 1 h before reperfusion. The mice receiving transient hindlimb ischemia/reperfu-
sion or sham treatment were individually placed in the centre of the observation cylinders, and their spontaneous 
behaviours were observed. The time spent licking the ipsilateral hindpaw was recorded every 1 min for 20 min or 
5 min for 60 min, and the total time spent licking was calculated for 40 min after the reperfusion.
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Tactile sensitivities to static and dynamic stimuli. Mice were individually habituated to the experimental con-
ditions of a metal mesh floor in a small cylinder (diameter, 7.5 cm; height, 10 cm) for at least 30 min. Their static 
tactile sensitivity was assessed for a few seconds using a 1 g von Frey filament (Stoelting Co., Wood Dale, IL, 
USA) applied until it bent slightly on the middle plantar surface of each hindpaw. The dynamic tactile sensitivity 
was assessed by lightly stroking the dorsal surface of each hindpaw with a paintbrush (Φ , 10 mm; Pentel, Tokyo, 
Japan). The paw-withdrawal response was graded using the following scores: 0, no response; 1, moderate effort to 
avoid the probe, such as licking the stimulated paw; and 2, vigorous effort to escape the stimulus, such as jumping, 
shaking the hindpaw, or biting at the probe or the stimulated paw. One trial involved five applications of a von 
Frey filament or a paintbrush every 3 or 4 s, each of which was scored as 0, 1, or 2. The trial was evaluated based 
on a total score of 0 to 10 at culmination.
Nocifensive behaviour evoked by intraplantar injection of H2O2. Mice were individually habituated to the exper-
imental conditions in an acrylic observation cylinder for approximately 1 h before H2O2 injection. Either H2O2 
(1.5%, 20 μL/paw) or saline (20 μL/paw) was subcutaneously injected into the plantar surface of the right hind-
paw, and the time spent in nocifensive behaviours, such as licking and flicking of the injected hindpaw, was meas-
ured for 5 min. DMOG (25 μg/paw) or saline (20 μL/paw) was subcutaneously injected into the plantar surface of 
the hindpaw 60 min before the H2O2 injection. HC-0300311 (100 mg/kg) or vehicle (0.5% methylcellulose) was 
administered i.p. 30 min before the H2O2 injection.
Measurement of H2O2 content. The content of H2O2 in the ischemic/reperfused paws was measured, 
as previously described44 with sight modifications. Mice were exposed to hindlimb ischemia for 60 min, and 
sacrificed by cervical dislocation 5 min after reperfusion. The plantar tissues were immediately removed from 
the contralateral and ipsilateral mouse hindpaws, frozen in liquid nitrogen, and stored at − 80 °C until use. They 
were homogenized with a Polytron homogenizer in ice-cold 50 mM phosphate buffer (pH 7.4) with 0.5% hexa-
decyltrimethylammonium bromide. The homogenates were centrifuged at 15,000 rpm, 4 °C for 2 min to remove 
debris. The supernatants were filtered through an Amicon Ultra Centrifugal Filter Unit with an Ultracel-100 
membrane (Merck Millipore, Billerica, MA) by centrifugation at 15,000 rpm, 4 °C for 2 min. The H2O2 content in 
the flow-through was determined with an Amplex Red Assay Kit (Invitrogen, Life Technologies, Carlsbad, CA), 
in accordance with the manufacturer’s protocol.
HEK293 cell culture and cDNA transfection. HEK293 cells were cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM; Sigma-Aldrich) supplemented with 10% heat-inactivated foetal bovine serum 
(Sigma-Aldrich), and maintained at 37 °C in a humidified incubator set at 5% CO2. Recombinant plasmids for 
hTRPA1, hTRPA1-P394A and mutPHD2 in pCI-neo mammalian expression vectors (Promega Co., Madison, 
WI) were constructed as previously described26. HEK293 cells were transfected with pCI-neo-hTRPA1 (2.0 μg) 
or pCI-neo-hTRPA1-P394A (2.0 μg) with pEGFP-C3 (0.5 μg), or cotransfected with pCI-neo-hTRPA1 (1.12 μg), 
pCI-neo-mutPHD2 (1.12 μg) and pEGFP-C3 (0.28 μg) by using Lipofectamine 2000 (Life Technologies, Carlsbad, 
CA). Two days after the transfection, cells were removed from the culture dish and plated onto coverslips coated 
with poly-L-lysine.
Primary cultures of mouse DRG neurons. Primary cultures of mouse DRG neurons were prepared as 
previously described29. C57BL/6 J (WT) or TRPA1-KO mice (aged 6–8 weeks) were decapitated, and bilateral L1–
L6 DRG were immediately harvested. The DRG were incubated for 1 h at 37 °C in Hank’s balanced salt solution 
containing (in mM) 137 NaCl, 5.4 KCl, 0.34 Na2HPO4, 0.44 KH2PO4, 5.6 D-glucose, and 2.4 HEPES (adjusted to 
pH 7.4 with NaOH) as well as 0.3% collagenase and 0.4% dispase. A Percoll (Sigma-Aldrich) gradient was used to 
separate DRG neurons from myelin and nerve debris as follows. Solutions of 30% and 60% Percoll were prepared 
with L15 medium. The 30% Percoll was gently layered over the 60% Percoll solution, and the cell suspension was 
layered over the Percoll gradient. After 10 min of centrifugation at 1,800 × g, the cells were harvested from the 
Percoll interface, suspended in 8 mL of L15 medium, and then centrifuged again for 5 min at 1,800 × g. The super-
natant was removed, and the cell pellet was resuspended in 70 μL of DMEM containing 10% heat-inactivated 
foetal bovine serum (Sigma), penicillin G (100 U/mL), and streptomycin (100 μg/mL). The cells were plating onto 
laminin-coated coverslips and incubated at 37 °C. After 4 h of incubation, 1.5 mL of DMEM was added, and the 
cells were incubated overnight at 37 °C.
Fluorometric Ca2+ imaging. Transfected HEK293 cells or cultured mouse DRG neurons on coverslips 
were loaded for 30–40 min with 5 μM fura-2 acetoxymethyl ester (Fura-2 AM; Dojindo Laboratories, Kumamoto, 
Japan) in Krebs-Ringer buffer containing (in mM) 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES 
along with 0.01% Cremophor EL (Sigma-Aldrich). The fluorescence images of the cells were recorded and ana-
lysed using a time-lapse image analysis system (HC Image; Hamamatsu Photonics, Shizuoka, Japan) equipped 
with a digital camera (ORCA-Flash 4.0, Hamamatsu Photonic) and an inverted microscope (ECLIPSE Ti-E; 
Nikon, Tokyo, Japan) according to the manufacturers’ instructions. The fluorescence images were captured every 
15 s using alternating excitation wavelengths of 340 and 380 nm, and an emission wavelength of 510 nm. The 
ratio of the fluorescence intensity obtained by the excitation/emission of 340 nm/510 nm (F340) to the fluores-
cence intensity obtained by the excitation/emission of 380 nm/510 nm (F380), namely F340/F380, was calculated 
to quantify [Ca2+]i. The cells with an F340/F380 ratio over 1.5 at baseline were excluded. The device was calibrated 
according to the manufacture’s protocol. In HEK293 cells treated with 4 μM ionomycin (Wako), the maximal 
F340/F380 ratio was 2.05 ± 0.001 in the presence of 2 mM Ca2+, and was saturated by more than 2 mM Ca2+. Once 
the calibrations were made, the device settings were fixed, and then measurements were made.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:23261 | DOI: 10.1038/srep23261
For statistical analyses, the change in the F340/F380 ratio (ΔRatio) was calculated from the baseline, which 
was defined as the average F340/F380 ratio for 3 min immediately before H2O2 application. In the experiments 
using HEK293 cells, the maximal ΔRatios during the 5 min H2O2 application period were calculated. In the 
experiments using mouse DRG neurons, H2O2-sensitive cells were defined as those having a maximal ΔRatio of 
more than 0.1 during the 5 min H2O2 application period. Statistical analyses were performed for the percentage 
of H2O2-sensitive cells within the 50 mM KCl-positive neurons. AITC and capsaicin were used to validate the 
expression of TRPA1 and TRPV1, respectively. To determine whether HEK293 cells or DRG neurons were alive, 
3 μM ionomycin or 50 mM KCl was applied, respectively.
Treatment with hypoxia and reoxygenation. The PO2 in the chamber was controlled with a Digital Gas 
Mixer GM-8000 (Tokai Hit, Shizuoka, Japan) under a Stage Top Incubator INUBSF-ZILCS (Tokai Hit, Shizuoka, 
Japan). The PO2 in Krebs-Ringer buffer was recorded using a Licox-JBOX (Medical Agent, Kyoto, Japan). The 
PO2 was reduced at a rate of approximately 2.7 mmHg/min to 100, 90 or 80 mmHg. The cells were exposed to the 
hypoxic condition for 30 min, and then the PO2 was rapidly returned to normoxia (160 mmHg) using the Digital 
Gas Mixer and by adding a double volume of normoxic buffer containing H2O2.
Statistical analysis. The data were analysed using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, 
CA) and are presented as the means ± S.E.M. Differences between two groups were compared using Student’s 
t-test. Data with more than two groups were compared using one-way or two-way analyses of variance (ANOVA), 
followed by the Bonferroni post hoc test. Time-course data were analysed using two-way ANOVA for repeated 
measures, followed by the Bonferroni post hoc test. In all cases, differences of p < 0.05 were considered statistically 
significant.
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